Balancing clinical benefits of vigabatrin with its associated risk of vision loss [PDF]
John M. Pellock
openalex +1 more source
Liquid Medication Dosing Errors: Comparison of a Ready-to-Use Vigabatrin Solution to Reconstituted Solutions of Vigabatrin Powder for Oral Solution. [PDF]
Gibson R, Klima R, Van Horn J.
europepmc +1 more source
One Size Does Not Fit All: Novel Individualized Use of Dexamethasone in Infantile Epileptic Spasms Syndrome. [PDF]
Kabak E +3 more
europepmc +1 more source
Infantile epileptic spasm syndrome: predictors of short- and long-term outcomes. [PDF]
Al-Omari MA +4 more
europepmc +1 more source
Long-term follow-up study of vigabatrin in pretreated children with west syndrome
H. Siemes +4 more
openalex +1 more source
Cholecystokinin‐8 sulfate modulates the anticonvulsant efficacy of vigabatrin in an experimental model of partial complex epilepsy in the rat [PDF]
Giuseppe Ferraro, Pierangelo Sardo
openalex +1 more source
TUBA1A-related tubulinopathy associated with the infantile epileptic spasms syndrome and atypical absence seizures. [PDF]
Ng AC, Scantlebury MH.
europepmc +1 more source
Effect of vigabatrin (gamma-vinyl GABA) on amino acid levels in CSF of epileptic patients. [PDF]
Asla Pitkänen +4 more
openalex +1 more source
Epidemiology of Epileptic Spasm and Affecting Factors on One-Year Prognosis: A Study in Tabriz Children's Hospital. [PDF]
Sadeghvand S +8 more
europepmc +1 more source

